Aarey Drugs & Pharmaceuticals Ltd

At Rs 86.00, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 4.98% on 30 Apr 2026, with unfilled sell orders and a frozen price.

At Rs 91.11, Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit on 29 Apr 2026, reflecting a 4.29% decline within a 5% price band. Sellers were lined up to exit, but buyers were absent, resulting in unfilled supply and a frozen price that underscores the liquidity challenges faced by this micro-cap stock.

Aarey Drugs & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

At Rs 85.39, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 24 Apr 2026, with unfilled sell orders and a frozen price.

At Rs 85.13, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 20 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 81.85, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 16 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

At Rs 75.03, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 15 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 68.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 09 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 65.26, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 3.76% on 9 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 62.16, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 5% on 8 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 59.20, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.98% on 7 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 56.39, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.45% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 53.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Aarey Drugs & Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 55.77, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 10% on 27 Mar 2026, with unfilled sell orders and a frozen price, marking a significant daily loss in a micro-cap stock with limited liquidity.

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.